Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,169–3,176 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Palatin Technologies Inc. PL9643 - (MELODY-1) Dry eye disease (DED) Phase 3 Data Released Ophthalmic Opthalmic
Palatin Technologies Inc. PL9643 - (MELODY-1) Dry eye disease (DED) Phase 3 Data Released Ophthalmic Opthalmic
Palatin Technologies Inc. BMT-801 with bremelanotide plus tirzepatide Obesity Phase 2 Data Released Subcutaneous Endocrinology
Palatin Technologies Inc. Bremelanotide with Tirzepatide (GLP-1) Obesity Phase 2 Enrollment Conclusion Subcutaneous injection Endocrinology
Palatin Technologies Inc. PL8177-205 Ulcerative colitis (UC) Phase 2 Data Released Oral Gastroenterology
Palatin Technologies Inc. PL-8177 Non-infectious uveitis Phase 2 Trial Planned Subcutaneous Opthalmic
Palatin Technologies Inc. PL-3994 Heart failure Phase 2a Trial Completed Intravenous Cardiology
Palisade Bio Inc. LB1148 Postoperative Return of Bowel Function Phase 3 Trial Discontinued Oral Gastroenterology